FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133719846> ?p ?o ?g. }

• W3133719846 endingPage "676" @default.
• W3133719846 startingPage "666" @default.
• W3133719846 abstract "Chronic hepatitis B virus (HBV) infection (CHB) is a public health concern worldwide. Current therapies utilizing nucleos(t)ide analogs (NA) have not resulted in a complete cure for CHB. Furthermore, patients on long-term NA treatment often develop low-level viremia (LLV). Persistent LLV, in addition to causing the progression of liver disease or hepatocellular carcinoma, may shed light on the current plight of NA therapy. Here, we review the literature on LLV, NA treatment, and various doses of entecavir to find a strategy for improving the efficacy of this antiviral agent. For LLV patients, three therapeutic options are available, switching to another antiviral monotherapy, interferon-α switching therapy, and continuing monotherapy. In real-world clinical practice, entecavir overdose has been used in antiviral therapy for CHB patients with NA refractory and persistent LLV, which encouraged us to conduct further in-depth literature survey on dosage and duration related entecavir studies. The studies of pharmacodynamics and pharmacokinetics show that entecavir has the maximal selected index for safety, and has great potential in inhibiting HBV replication, in all of the NAs. In the particular section of the drug approval package published by the United States Food and Drug Administration, entecavir doses 2.5-20 mg/d do not increase adverse events, and entecavir doses higher than 1.0 mg/d might improve the antiviral efficacy. The literature survey led us to two suggestions: (1) Increasing entecavir dose to 1.0 mg/d for the treatment of NA naive patients with HBV DNA >2 × 106 IU/mL is feasible and would provide better prognosis; and (2) Further research is needed to assess the long-term toxic effects of higher entecavir doses (2.5 and 5.0 mg/d), which may prove beneficial in treating patients with prior NA treatment, partial virological response, or LLV state." @default.
• W3133719846 created "2021-03-15" @default.
• W3133719846 creator A5018468485 @default.
• W3133719846 creator A5027835055 @default.
• W3133719846 creator A5034023092 @default.
• W3133719846 creator A5065406042 @default.
• W3133719846 creator A5091233158 @default.
• W3133719846 date "2021-02-28" @default.
• W3133719846 modified "2023-09-27" @default.
• W3133719846 title "New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage" @default.
• W3133719846 cites W1482153588 @default.
• W3133719846 cites W1907806866 @default.
• W3133719846 cites W1934714460 @default.
• W3133719846 cites W1980880594 @default.
• W3133719846 cites W1993236995 @default.
• W3133719846 cites W1995495726 @default.
• W3133719846 cites W2007016356 @default.
• W3133719846 cites W2042565956 @default.
• W3133719846 cites W2051966118 @default.
• W3133719846 cites W2056599541 @default.
• W3133719846 cites W2060900308 @default.
• W3133719846 cites W2063059443 @default.
• W3133719846 cites W2064209815 @default.
• W3133719846 cites W2075528292 @default.
• W3133719846 cites W2100256719 @default.
• W3133719846 cites W2108435608 @default.
• W3133719846 cites W2111909422 @default.
• W3133719846 cites W2117947644 @default.
• W3133719846 cites W2130575875 @default.
• W3133719846 cites W2138240824 @default.
• W3133719846 cites W2152207030 @default.
• W3133719846 cites W2173698250 @default.
• W3133719846 cites W2481556475 @default.
• W3133719846 cites W2548902797 @default.
• W3133719846 cites W2569712993 @default.
• W3133719846 cites W2605200021 @default.
• W3133719846 cites W2727153390 @default.
• W3133719846 cites W2739683242 @default.
• W3133719846 cites W2751981888 @default.
• W3133719846 cites W2789283804 @default.
• W3133719846 cites W2791839818 @default.
• W3133719846 cites W2935959369 @default.
• W3133719846 cites W4232807133 @default.
• W3133719846 doi "https://doi.org/10.3748/wjg.v27.i8.666" @default.
• W3133719846 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7934007" @default.
• W3133719846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33716446" @default.
• W3133719846 hasPublicationYear "2021" @default.
• W3133719846 type Work @default.
• W3133719846 sameAs 3133719846 @default.
• W3133719846 citedByCount "6" @default.
• W3133719846 countsByYear W31337198462021 @default.
• W3133719846 countsByYear W31337198462022 @default.
• W3133719846 countsByYear W31337198462023 @default.
• W3133719846 crossrefType "journal-article" @default.
• W3133719846 hasAuthorship W3133719846A5018468485 @default.
• W3133719846 hasAuthorship W3133719846A5027835055 @default.
• W3133719846 hasAuthorship W3133719846A5034023092 @default.
• W3133719846 hasAuthorship W3133719846A5065406042 @default.
• W3133719846 hasAuthorship W3133719846A5091233158 @default.
• W3133719846 hasBestOaLocation W31337198461 @default.
• W3133719846 hasConcept C159047783 @default.
• W3133719846 hasConcept C203014093 @default.
• W3133719846 hasConcept C2522874641 @default.
• W3133719846 hasConcept C2776175608 @default.
• W3133719846 hasConcept C2776185481 @default.
• W3133719846 hasConcept C2777869810 @default.
• W3133719846 hasConcept C2780593183 @default.
• W3133719846 hasConcept C3019983190 @default.
• W3133719846 hasConcept C3020491458 @default.
• W3133719846 hasConcept C71924100 @default.
• W3133719846 hasConceptScore W3133719846C159047783 @default.
• W3133719846 hasConceptScore W3133719846C203014093 @default.
• W3133719846 hasConceptScore W3133719846C2522874641 @default.
• W3133719846 hasConceptScore W3133719846C2776175608 @default.
• W3133719846 hasConceptScore W3133719846C2776185481 @default.
• W3133719846 hasConceptScore W3133719846C2777869810 @default.
• W3133719846 hasConceptScore W3133719846C2780593183 @default.
• W3133719846 hasConceptScore W3133719846C3019983190 @default.
• W3133719846 hasConceptScore W3133719846C3020491458 @default.
• W3133719846 hasConceptScore W3133719846C71924100 @default.
• W3133719846 hasIssue "8" @default.
• W3133719846 hasLocation W31337198461 @default.
• W3133719846 hasLocation W31337198462 @default.
• W3133719846 hasOpenAccess W3133719846 @default.
• W3133719846 hasPrimaryLocation W31337198461 @default.
• W3133719846 hasRelatedWork W1933588764 @default.
• W3133719846 hasRelatedWork W2020403813 @default.
• W3133719846 hasRelatedWork W2024933756 @default.
• W3133719846 hasRelatedWork W2033980504 @default.
• W3133719846 hasRelatedWork W2046657202 @default.
• W3133719846 hasRelatedWork W2057745002 @default.
• W3133719846 hasRelatedWork W2082080978 @default.
• W3133719846 hasRelatedWork W2150845218 @default.
• W3133719846 hasRelatedWork W2165013436 @default.
• W3133719846 hasRelatedWork W3032116559 @default.
• W3133719846 hasVolume "27" @default.
• W3133719846 isParatext "false" @default.
• W3133719846 isRetracted "false" @default.

• next